NCT01857427

Brief Summary

The primary objective of this study is to build a well characterized cohort of patients that will be used to determine the genetic variants associated with obstructive sleep apnea (OSA)and its co-morbidities.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Aug 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Aug 2012Dec 2026

Study Start

First participant enrolled

August 1, 2012

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 20, 2013

Completed
13.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

14.3 years

First QC Date

May 10, 2013

Last Update Submit

March 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sleep Questionnaire

    Responses to sleep questionnaire

    upon enrollment

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult subjects 18 years of age and older who are scheduled for polysomnography (PSG), regardless of final diagnosis AND adult subjects who have already been diagnosed with OSA based on a prior PSG and are already on treatment. OSA diagnosis will be defined as an apnea/hypopnea index (AHI) \>or =5 episodes per hour.

You may qualify if:

  • We will recruit subjects who are:
  • years of age and older.
  • Willing and able to give informed consent
  • AND any of the following:
  • PSG (polysomnogram)requested by a physician based on clinical grounds
  • AHI (Apnea-hypopnea index) ≥ 5 episodes per hour based on a prior PSG.

You may not qualify if:

  • Incapable of giving informed consent
  • Under the age of 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suite 2600, Martha Morehouse Medical Pavilion

Columbus, Ohio, 43221, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood or saliva sample

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Ulysses Magalang, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Internal Medicine

Study Record Dates

First Submitted

May 10, 2013

First Posted

May 20, 2013

Study Start

August 1, 2012

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations